CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +272,575 | 272,575 | ||
| 2025-02-27 | Love Douglas PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +1,300,000 | 1,300,000 | ||
| 2025-02-27 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award · Stock Option (Right to Buy) | +272,575 | 272,575 | ||
| 2025-02-27 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award · Stock Option (Right to Buy) | +272,575 | 272,575 | ||
| 2025-02-18 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | −5,521 | $2.96 | $16K | 33,479 |
| 2025-02-18 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | −5,515 | $2.97 | $16K | 83,814 |
| 2025-02-18 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −8,345 | $2.91 | $24K | 61,237 |
| 2025-02-18 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −6,618 | $2.95 | $20K | 86,579 |
| 2025-02-18 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −6,912 | $2.92 | $20K | 77,770 |
| 2025-02-13 | Love Douglas PRESIDENT AND CEO | Sale | −5,021 | $2.95 | $15K | 351,554 |
| 2025-02-13 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,786 | $2.98 | $5K | 84,682 |
| 2025-02-13 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −1,783 | $2.99 | $5K | 69,582 |
| 2025-02-13 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −1,425 | $2.99 | $4K | 93,197 |
| 2025-01-09 | JONES WILLIAM A JR Director | Grant or award · Stock Option (Right to Buy) | +88,000 | 88,000 | ||
| 2025-01-06 | Love Douglas PRESIDENT AND CEO | Option exercise | +37,994 | $1.41 | $54K | 356,575 |
| 2025-01-06 | Love Douglas PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −37,994 | 0 | ||
| 2024-12-02 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $5.33 | $17K | 25,600 |
| 2024-10-30 | Love Douglas PRESIDENT AND CEO | Option exercise | +78,399 | $1.85 | $145K | 274,520 |
| 2024-10-30 | Love Douglas PRESIDENT AND CEO | Option exercise | +36,050 | $1.85 | $67K | 310,570 |
| 2024-10-30 | Love Douglas PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −78,399 | 0 |
Page 4 of 15 · 292 trades